VPS45 (Vacuolar Protein Sorting 45 Homolog) is a critical regulator of intracellular membrane trafficking, particularly within the endosomal and secretory pathways. VPS45 is a member of the Sec1/Munc18 (SM) family of proteins that play essential roles in vesicle trafficking and membrane fusion events throughout the cell [1]. The protein is encoded by the VPS45 gene located on chromosome 1q21.2 and is highly conserved across eukaryotes, reflecting its fundamental role in cellular physiology.
[^1]
[^2]
[^3]
[^4]
[^5]
[^6]
[^7]
[^8]
[^9]
| Symbol | VPS45 |
|---|
| Full Name | Vacuolar Protein Sorting 45 Homolog |
|---|
| Aliases | VPS45, Vacuolar protein sorting-associated protein 45, Mvps45 |
|---|
| Chromosomal Location | Chr1q21.2 |
|---|
| NCBI Gene ID | 11005 |
|---|
| OMIM | 614353 |
|---|
| Ensembl ID | ENSG00000136631 |
|---|
| UniProt ID | Q9NRW8 |
|---|
| Associated Diseases | Neutropenia, Neurodegeneration, Griscelli syndrome |
|---|
¶ Protein Structure and Function
¶ Domain Architecture
VPS45 is a 524-amino acid protein belonging to the Sec1/Munc18 (SM) family. Like other SM proteins, VPS45 consists of a single α-helical domain organized into three subdomains that form a arch-like structure [2]. This architecture allows VPS45 to bind to SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) proteins and regulate their function in membrane fusion.
VPS45 participates in several critical cellular processes:
-
Endosomal Trafficking: VPS45 is a key regulator of transport between the Golgi apparatus, endosomes, and lysosomes. It functions as a molecular chaperone for SNARE proteins involved in endosomal sorting [3].
-
Lysosomal Delivery: VPS45 directs cargo proteins to lysosomes by regulating the fusion of transport vesicles with late endosomes and lysosomes [4].
-
Autophagosome Maturation: Recent studies have revealed that VPS45 plays a important role in autophagy, facilitating the fusion of autophagosomes with lysosomes [5].
-
Secretory Pathway Regulation: VPS45 participates in regulated secretion and constitutive secretory pathway function [6].
VPS45 interacts with multiple components of the trafficking machinery:
- SNARE Proteins: VPS45 binds to syntaxin proteins (particularly Syntaxin 16 and Syntaxin 6) to regulate SNARE complex assembly
- Rab GTPases: Works with Rab5 and Rab7 in early and late endosome function
- HOPS Complex: Collaborates with the homotypic fusion and vacuole protein sorting (HOPS) complex for late endosome-lysosome fusion
- ESCRT Machinery: Functions in endosomal sorting complex required for transport (ESCRT) pathways
VPS45 is ubiquitously expressed across human tissues, with highest expression in hematopoietic cells, brain tissue, and secretory epithelia [7]. In the central nervous system, VPS45 is expressed in neurons and glial cells, including astrocytes and microglia. The protein localizes primarily to the cytoplasm and is associated with intracellular membrane compartments, particularly endosomes and the trans-Golgi network.
Emerging evidence suggests that VPS45 dysfunction may contribute to Alzheimer's disease pathogenesis through several mechanisms [8]:
- Amyloid Processing: VPS45 regulates trafficking of the amyloid precursor protein (APP) and β-secretase (BACE1), affecting amyloid-β production
- Autophagy Impairment: Defective VPS45 function leads to impaired autophagic clearance of protein aggregates, including amyloid plaques and neurofibrillary tangles
- Lysosomal Dysfunction: VPS45 mutations contribute to lysosomal membrane permeabilization and release of toxic hydrolases
- Synaptic Vesicle Trafficking: VPS45 regulates synaptic vesicle recycling and neurotransmitter release
VPS45 has been implicated in Parkinson's disease through its role in:
- α-Synuclein Clearance: Autophagy-lysosomal pathways regulated by VPS45 are critical for clearing α-synuclein aggregates
- Mitochondrial Quality Control: VPS45-mediated trafficking contributes to mitochondrial dynamics and mitophagy
- Dopaminergic Neuron Survival: The protein supports the specialized trafficking requirements of dopaminergic neurons
In ALS, VPS45 dysfunction may contribute to disease through:
- Protein Aggregate Clearance: Impaired autophagy leads to accumulation of TDP-43 and SOD1 aggregates
- Axonal Transport Defects: VPS45 regulates trafficking of organelles and signaling complexes in motor neurons
- Lysosomal Storage Abnormalities: Altered lysosomal function contributes to neurodegeneration
Biallelic VPS45 mutations cause a form of Griscelli syndrome characterized by [9]:
- Severe congenital neutropenia
- Immune dysfunction
- Partial albinism
- Neurological involvement including developmental delay and neurodegeneration
VPS45 is a critical regulator of autophagosome-lysosome fusion. The protein facilitates the recruitment of the HOPS complex to autophagosomes, promoting their maturation into autolysosomes [10]. When VPS45 function is impaired:
- Autophagosomes accumulate in the cytoplasm
- Protein aggregates fail to be cleared
- Damaged organelles are not removed
- Cellular stress triggers apoptotic pathways
VPS45 regulates endosomal trafficking and cargo sorting. Dysfunction leads to:
- Mis-sorting of transmembrane proteins
- Impaired receptor degradation
- Altered signaling pathway activation
- Accumulation of undegraded material in multivesicular bodies
As an SM protein, VPS45 regulates SNARE complex assembly. Proper SNARE function is essential for:
- Synaptic vesicle fusion and neurotransmitter release
- Endosomal membrane fusion events
- Lysosomal fusion with cargo-containing vesicles
While specific VPS45 inhibitors are not yet in clinical use, understanding VPS45 function has led to therapeutic strategies targeting related pathways:
- Autophagy modulators (e.g., rapamycin, trehalose) can compensate for VPS45 dysfunction
- Lysosomal function enhancers show promise in preclinical models
- SNARE complex stabilizers are under investigation
VPS45 gene therapy represents a potential treatment for VPS45-related neurodegeneration:
- Adeno-associated virus (AAV) vectors can deliver functional VPS45
- CRISPR-based gene editing could correct disease-causing mutations
- mRNA delivery approaches are being explored
VPS45 expression and function may serve as biomarkers:
- VPS45 levels in cerebrospinal fluid correlate with disease progression
- Lymphocyte VPS45 activity reflects systemic trafficking function
- Imaging markers of lysosomal dysfunction may indicate VPS45 impairment
- RT-PCR and RNA Sequencing: Measure VPS45 mRNA expression
- Western Blotting: Detect VPS45 protein levels and modifications
- Immunofluorescence: Localize VPS45 in cells and tissues
- Live Cell Imaging: Track VPS45 and cargo trafficking in real time
- Electron Microscopy: Examine ultrastructural changes in VPS45 deficiency
- Co-immunoprecipitation: Identify VPS45 interaction partners
- Knockout Mice: Reveal developmental and physiological consequences of VPS45 loss
- Conditional Knockouts: Study tissue-specific VPS45 function
- Transgenic Models: Express mutant VPS45 to model disease
- Genetic Screening: Identify VPS45 mutations in patients
- Clinical Trials: Test therapeutic interventions in VPS45-related disorders